Pliant Therapeutics (PLRX) Receivables - Accured (2021 - 2026)
Pliant Therapeutics (PLRX) reported Receivables - Accured of $873,000 for Q2 2026, down 43.1% from $1.54 million a year earlier and down 4.5% from the prior quarter.
Powered by 
Analysis
Pliant Therapeutics (PLRX) Receivables - Accured (2021 - 2026) Analysis & Trends
At the end of FY2025, Pliant Therapeutics posted Receivables - Accured of $823,000, down 64.2% from FY2024.
- Receivables - Accured has a four-year compound annual growth rate of 20.9% (FY2021 to FY2025).
- By year, Receivables - Accured came in at $2.3 million in FY2024 (-23.2%), $3 million in FY2023 (+178.0%), $1.08 million in FY2022 (+180.0%) and $385,000 in FY2021.
- Five-year quarterly Receivables - Accured spans a low of $320,000 in Q2 2022 and a high of $3 million in Q4 2023.
- Year over year, Receivables - Accured has now declined in each of the last seven quarters, with an average decline of 37.4% over the last eight quarters.
- The high point for year-over-year Receivables - Accured in five years was Q2 2023 (growth of 639.1%); the low point was Q4 2025 (a decline of 64.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $914,000 (Q1 2026), $823,000 (Q4 2025) and $908,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Pliant Therapeutics | 66.87 Mn | 66.87 Mn | - | 873,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 873,000.00 |
| Mar 31, 2026 | 914,000.00 |
| Dec 31, 2025 | 823,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 2.37 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 752,000.00 |
| Jun 30, 2022 | 320,000.00 |
| Mar 31, 2022 | 443,000.00 |
| Dec 31, 2021 | 385,000.00 |
API Access
Pliant Therapeutics Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=PLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "PLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=PLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();